EHA 2019: Burning out the T-ALL engine: NADK is a new therapeutic target in T-cell Acute Lymphoblastic Leukaemia
T-cell acute lymphoblastic leukaemia (T-ALL) is an aggressive cancer which is lethal to 15% of…
Browsing: CRISPR-Cas9-based method
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- The OJC Episode 30: ctDNA Special
- Researchers explain the toxicity of USP7 inhibitors, under development for cancer treatment
- Antibody–Drug Combo Designed To Combat Rare Blood Cancer
- Potential drug candidates for difficult-to-treat paediatric leukaemia
- New “time machine” technique to measure cells
- Scientists identify potential drug candidates for deadly paediatric leukaemia
- Protein found to control drivers of normal growth and cancer
- Cellular “hotspots” in the brain may signify the earliest signs of cancer
